Data Capture Solutions News Today

TOKYO & TAIPEI, Taiwan, October 11, 2023--October 11, 2023, SATO Holdings Corporation (TOKYO: 6287), a global pioneer in auto-ID and labeling solutions and CipherLab (TWO: 6160), a prominent international supplier of auto-ID and data capture solutions today unveiled an integrated enterprise mobility management (EMM) software solution, ReMoCloud × SOS1. This software solution empowers users with seamless access to remote maintenance support and device maintenance for SATO’s label...

Scheduling an OR procedure can be a complicated task. Authorizationfor payment, special patient needs and compliance with legal and...

The consequences of Hurricane Ian are expected to increase the risk of Vibrio vulnificus and other waterborne infections.

Approvals for innovator small molecules treating rare diseases in China rose by 22% from 2020 to 2022, giving hope to rare disease patients.

Chronic obstructive pulmonary disease is a group of progressive chronic inflammatory lung conditions that cause breathing difficulties.

TauRx announced topline results from its Phase III LUCIDITY trial evaluating its oral anti-tau product, hydromethylthionine mesylate.

Leading up to 2025, AstraZeneca plans to expand its scope through new acquisitions, says Pascal Soriot.

Of the 105 million total prevalent chronic kidney disease cases forecast for the 7MM this year, only 18 million are expected to be diagnosed.

Gemini Therapeutics signed an agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical firm.

AIM ImmunoTech has reported positive initial pilot study data from its Phase III trial of an investigational drug, Ampligen, for long Covid.